Literature DB >> 26037262

Modified One-layer Duct-to-mucosa Pancreaticojejunostomy Reduces Pancreatic Fistula After Pancreaticoduodenectomy.

Jishu Wei1, Xinchun Liu2, Junli Wu, Wenbin Xu, Jia Zhou, Zipeng Lu, Jianmin Chen, Feng Guo, Wentao Gao, Qiang Li, Kuirong Jiang, Cuncai Dai, Yi Miao3.   

Abstract

Postoperative pancreatic fistula (POPF) is a major source of morbidity after pancreaticoduodenectomy (PD). The purpose of this retrospective study comparing one-layer pancreaticojejunostomy (PJ) with two-layer PJ after PD was to evaluate whether the one-layer duct-to-mucosa PJ after PD can reduce the incidence of POPF.A total of 194 consecutive patients who underwent PD by one surgeon (Y. Miao) from January 2011 to February 2014 were included in this study. Among those patients, 104 underwent one-layer PJ (one-layer group) and 90 patients underwent two-layer PJ (two-layer group), respectively. Preoperative clinicopathologic features, intraoperative parameters, postoperative morbidity with focus on POPF, were compared between the two groups.The overall incidence of POPF was 19.6% (38/194), and clinically relevant grade B/C POPF rates were 8.6% (16/194) and 3.1% (6/194), respectively. There were no differences in patients' demographics and operation related factors between the two groups. However, the incidence of POPF in the one-layer group was significantly lower than in two-layer group (13.5% [14/104 patients] and 26.7% [24/90 patients] respectively; p=0.021). The median postoperative hospital stay was also significantly lower in the one-layer group compared to the two-layer group (13 days vs. 15 days, p=0.035). One patient in two-layer group died due to postoperative hemorrhage.One-layer duct-to-mucosa pancreaticojejunostomy is a simple and easy technique for pancreaticojejunal anastomosis after PD, and can reduce the POPF rate in comparison to the two-layer technique.

Entities:  

Keywords:  Pancreaticoduodenectomy - Pancreatic fistula - Pancreaticojejunostomy - Morbidity

Year:  2015        PMID: 26037262     DOI: 10.9738/INTSURG-D-15-00094.1

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  6 in total

1.  Development and validation of risk prediction nomogram for pancreatic fistula and risk-stratified strategy for drainage management after pancreaticoduodenectomy.

Authors:  Jie Yin; Qicong Zhu; Kai Zhang; Wentao Gao; Junli Wu; Zipeng Lu; Kuirong Jiang; Yi Miao
Journal:  Gland Surg       Date:  2022-01

Review 2.  Duct-to-mucosa versus other types of pancreaticojejunostomy for the prevention of postoperative pancreatic fistula following pancreaticoduodenectomy.

Authors:  Hua Hai; Zhuyin Li; Ziwei Zhang; Yao Cheng; Zuojin Liu; Jianping Gong; Yilei Deng
Journal:  Cochrane Database Syst Rev       Date:  2022-03-15

3.  Afferent Loop Decompression Technique is Associated with a Reduction in Pancreatic Fistula Following Pancreaticoduodenectomy.

Authors:  Jie Yin; Zipeng Lu; Pengfei Wu; Junli Wu; Wentao Gao; Jishu Wei; Feng Guo; Jianmin Chen; Kuirong Jiang; Yi Miao
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

4.  One-layer versus two-layer duct-to-mucosa pancreaticojejunostomy after pancreaticoduodenectomy: study protocol for a randomized controlled trial.

Authors:  Shu-Bo Pan; Wei Geng; Da-Chen Zhou; Jiang-Ming Chen; Hong-Chuan Zhao; Fu-Bao Liu; Sheng-Xue Xie; Hui Hou; Yi-Jun Zhao; Kun Xie; Guo-Bin Wang; Xiao-Ping Geng
Journal:  Trials       Date:  2016-08-17       Impact factor: 2.279

5.  Undifferentiated Carcinoma of Pancreas with Osteoclast-Like Giant Cells: One Center's Experience of 13 Cases and Characteristic Pre-Operative Images.

Authors:  Yong Gao; Baobao Cai; Lingdi Yin; Guoxin Song; Zipeng Lu; Feng Guo; Jianmin Chen; Chunhua Xi; Jishu Wei; Junli Wu; Wentao Gao; Kuirong Jiang; Yi Miao
Journal:  Cancer Manag Res       Date:  2022-04-11       Impact factor: 3.602

Review 6.  Pancreaticojejunostomy Conducive to Biological Healing in Minimally Invasive Pancreaticoduodenectomy.

Authors:  Ying-Wen Gai; Huai-Tao Wang; Xiao-Dong Tan
Journal:  J Gastrointest Surg       Date:  2022-05-11       Impact factor: 3.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.